🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to assess the efficacy and safety of NGX-4010 a...
Status
Completed
Location
Multiple Locations
Start Date
2006-03
Trial ID
NCT00300222
Treatments Being Tested
The purpose of the study is to assess the efficacy and safety of NGX-4010 a...
Status
Completed
Location
Multiple Locations
Start Date
2005-06
Trial ID
NCT00115310
Treatments Being Tested
The purpose of the study is determine if an investigational drug, NGX-4010 ...
Status
Completed
Location
NeurogesX Investigational Site
Start Date
TBD
Trial ID
NCT00061776
Treatments Being Tested
The aim of this study is to monitor the effectiveness and used dosage of th...
Status
Completed
Location
Site CZ42019 Hospital
Start Date
2014-01
Trial ID
NCT02171182
Treatments Being Tested
The purpose of the study is to determine if an investigational drug, NGX-40...
Status
Completed
Location
NeurogesX Investigational Site
Start Date
2003-08
Trial ID
NCT00064623
Treatments Being Tested
This study is an open-label multi-center to evaluate the tolerability of tr...
Status
Completed
Location
Anchor Research Center
Start Date
2009-06
Trial ID
NCT00916942
Treatments Being Tested
This study is comparing the efficacy and tolerability of Qutenza with that ...
Status
Completed
Location
Site 101 Medical Union 2
Start Date
2012-07-11
Trial ID
NCT01713426
Treatments Being Tested
The purpose of the study was to assess the efficacy and safety of NGX-4010 ...
Status
Completed
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT00321672
This study is an open-label, multicenter, extension study for subjects who ...
Status
Terminated
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00089557
Treatments Being Tested
The purpose of this study is to evaluate epidermal nerve fiber (ENF) regene...
Status
Completed
Location
NeurogesX Investigational Site
Start Date
2005-11
Trial ID
NCT00254449
Treatments Being Tested